Search Results - tumor+infiltrating+leukocytes+(til)

1 Results

Sort By:

Improved Personalized Cancer Immunotherapy

Abstract: Scientists at NIH have identified a process to select highly tumor-reactive T cells from a patient tumor sample based on the expression of four specific T cell surface markers: programmed cell death protein 1 (PD-1; CD279), 4-1BB (CD137), T cell lg-and mucin-domain-containing molecule-3 (TIM-3), and/or lymphocyte activation gene 3 (LAG-3)....

Published: 4/8/2024 | Inventor(s): Alena Gros, Steven Rosenberg

Keywords(s): adoptive cell transfer (ACT), T Cells, tumor infiltrating leukocytes (TIL)

Category(s): Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Oncology